<?xml version="1.0" encoding="UTF-8"?>
<rootTag>
<Award>
<AwardTitle>SBIR Phase I:  COVID-19 Detection on a Handheld Smartphone-Enabled Platform</AwardTitle>
<AGENCY>NSF</AGENCY>
<AwardEffectiveDate>07/01/2020</AwardEffectiveDate>
<AwardExpirationDate>06/30/2021</AwardExpirationDate>
<AwardTotalIntnAmount>256000.00</AwardTotalIntnAmount>
<AwardAmount>256000</AwardAmount>
<AwardInstrument>
<Value>Standard Grant</Value>
</AwardInstrument>
<Organization>
<Code>07070000</Code>
<Directorate>
<Abbreviation>ENG</Abbreviation>
<LongName>Directorate For Engineering</LongName>
</Directorate>
<Division>
<Abbreviation>IIP</Abbreviation>
<LongName>Div Of Industrial Innovation &amp; Partnersh</LongName>
</Division>
</Organization>
<ProgramOfficer>
<SignBlockName>Anna Brady-Estevez</SignBlockName>
<PO_EMAI>abrady@nsf.gov</PO_EMAI>
<PO_PHON>7032927077</PO_PHON>
</ProgramOfficer>
<AbstractNarration>The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project is a handheld smartphone-enabled hardware platform for the rapid detection of COVID-19 in nasal swab samples. The proposed project will translate a portable smartphone enabled platform to detect COVID-19 in patient samples in 30-90 minutes in a standard clinical setting or in an even lower-resource facility. After diagnosis, data are immediately recorded and encrypted with geo-mapped and time-stamped for public health use. This novel and proactive approach for detection can enable communities to rapidly detect COVID-19 and monitor outbreak data to suppress disease spread. &lt;br/&gt;&lt;br/&gt;This Small Business Innovation Research (SBIR) Phase I project addresses the need to develop a rapid and portable COVID-19 point-of-care diagnostic. The scope of the Phase I project is to develop a robust nucleic acid assay to specifically and sensitively detect for COVID-19 in a handheld smartphone-enabled device. This project proposes an optimized nucleic acid amplification assay that is highly selective and rapid, while maintaining sensitivity, specificity, and a low false positive rate. Additionally, the project will test the optimized assay in the presence of nasopharyngeal (nasal) swabs and viral transport media, preparing a robust platform for clinical analysis of both fresh and stored samples. The project will integrate the assay into a sample-to-answer device for fast COVID-19 nucleic acid diagnosis.&lt;br/&gt;&lt;br/&gt;This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.</AbstractNarration>
<MinAmdLetterDate>07/06/2020</MinAmdLetterDate>
<MaxAmdLetterDate>07/06/2020</MaxAmdLetterDate>
<ARRAAmount/>
<TRAN_TYPE>Grant</TRAN_TYPE>
<CFDA_NUM>47.041</CFDA_NUM>
<NSF_PAR_USE_FLAG>1</NSF_PAR_USE_FLAG>
<FUND_AGCY_CODE>4900</FUND_AGCY_CODE>
<AWDG_AGCY_CODE>4900</AWDG_AGCY_CODE>
<AwardID>2028308</AwardID>
<Investigator>
<FirstName>Katherine</FirstName>
<LastName>Clayton</LastName>
<PI_MID_INIT>N</PI_MID_INIT>
<PI_SUFX_NAME/>
<PI_FULL_NAME>Katherine N Clayton</PI_FULL_NAME>
<EmailAddress>kclayton@omnivistech.com</EmailAddress>
<PI_PHON>4153099524</PI_PHON>
<NSF_ID>000763091</NSF_ID>
<StartDate>07/06/2020</StartDate>
<EndDate/>
<RoleCode>Principal Investigator</RoleCode>
</Investigator>
<Institution>
<Name>Omnivis LLC</Name>
<CityName>South San Francisco</CityName>
<CountyName>SAN MATEO</CountyName>
<ZipCode>940806883</ZipCode>
<PhoneNumber>4159384300</PhoneNumber>
<StreetAddress>280 Utah Avenue</StreetAddress>
<StreetAddress2><![CDATA[Suite 200]]></StreetAddress2>
<CountryName>United States</CountryName>
<StateName>California</StateName>
<StateCode>CA</StateCode>
<CONGRESSDISTRICT>07</CONGRESSDISTRICT>
<CONGRESS_DISTRICT_ORG>CA07</CONGRESS_DISTRICT_ORG>
<ORG_DUNS_NUM>080918577</ORG_DUNS_NUM>
<ORG_LGL_BUS_NAME>OMNIVIS INC</ORG_LGL_BUS_NAME>
<ORG_PRNT_DUNS_NUM/>
</Institution>
<Performance_Institution>
<Name><![CDATA[OmniVis, LLC]]></Name>
<CityName>San Francisco</CityName>
<CountyName>SAN FRANCISCO</CountyName>
<StateCode>CA</StateCode>
<ZipCode>941111904</ZipCode>
<StreetAddress><![CDATA[620 Davis St]]></StreetAddress>
<CountryCode>US</CountryCode>
<CountryName>United States</CountryName>
<StateName>California</StateName>
<CountryFlag>1</CountryFlag>
<CONGRESSDISTRICT>12</CONGRESSDISTRICT>
<CONGRESS_DISTRICT_PERF>CA12</CONGRESS_DISTRICT_PERF>
</Performance_Institution>
<ProgramElement>
<Code>5371</Code>
<Text>SBIR Phase I</Text>
</ProgramElement>
<ProgramReference>
<Code>096Z</Code>
<Text>COVID-19 Research</Text>
</ProgramReference>
<ProgramReference>
<Code>8030</Code>
<Text>Chemical Technology</Text>
</ProgramReference>
<ProgramReference>
<Code>8034</Code>
<Text>Hardware Components</Text>
</ProgramReference>
<Appropriation>
<Code>0120</Code>
<Name>NSF RESEARCH &amp; RELATED ACTIVIT</Name>
<APP_SYMB_ID>040100</APP_SYMB_ID>
</Appropriation>
<FUND_OBLG>2020~256000</FUND_OBLG>
</Award>
</rootTag>
